1/ The last time you heard from me about Spring Science, we were going to wind down. Then a really cool thing happened. I am proud to share that Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area*, where it will serve more scientists than ever before.

16/ Finally, there’s now a group of 18 ridiculously talented, hard-working, gritty, mission-driven, and startup-battle-hardened AI engineers, scientists, and software developers – plus a great startup ops person – who are in need of a home. A team of this caliber is as rare as they come. My loss, your opportunity. Ping me ASAP if you want details.

1/ Spring’s AI tools are loved by scientists. But we do not make enough money to continue running the company. Our tech gives ground-breaking new superpowers to researchers and has helped therapeutics groups around the world, from big pharma to biotech to rare disease orgs to academia. At the same time, we’ve struggled to find a business model that can support our operations. We’ve made the difficult decision to wind down. We know the closure of Spring leaves a major gap in the market. We’re currently having many discussions about ways for our platform’s impact to live on. I’m entertaining ideas here, more at the end.